Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

https://www.soho2020.com/

 

Myeloma
16:06

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Update on Smoldering MM: Why Should We Not Treat It Early?

FEATURING Angela Dispenzieri
  • 136 views
  • December 14, 2020
  • 1
15:23

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on Frontline MM for Older Adults: Does Biologic Age and Frailty Contribute to Treatment Outcomes? KMP vs. VMP - Is There a Difference in PFS for Transplant Ineligible Disease? Which Patients Should Get ASCT?

FEATURING Brea Lipe
  • 14 views
  • November 9, 2020
16:22

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

SOHO Debate: Frontline Therapy for Fit MM Patients Should Include an Antibody

FEATURING Peter Voorhees
  • 276 views
  • November 9, 2020
  • 2
15:07

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Updates on Newly Diagnosed MM: When Should Antibodies Be Included? What Are the Treatment Outcomes With KRd + ASCT? Is Daratumumab Beneficial for High-Risk Disease?

FEATURING Thomas Martin
  • 128 views
  • November 9, 2020
14:07

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Updates on Smoldering Myeloma: Should We Initiate Treatment Earlier? How to Identify High-Risk Subgroups? Is Len-Dex Combo More Beneficial Than Observation?

FEATURING Maria-Victoria Mateos
  • 25 views
  • November 9, 2020
14:57

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on HDT in Frontline MM: Is Lenalidomide, Bortezomib, and Dexamethasone (RVD) Regimen a Beneficial Approach? What Is the Effect of MRD Status on PFS and OS?

FEATURING Ajay Nooka
  • 116 views
  • November 9, 2020
  • 1
13:12

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Updates on R/R MM: Can Current Drugs Be Effective in New Combinations? Can We Overcome Prior Drug Resistance With Novel Drugs?

FEATURING Robert Z. Orlowski
  • 519 views
  • November 9, 2020
  • 2
09:45

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on Newly Diagnosed MM: How Does Daratumumab + RVd Combination Affect ORR and MRD Negativity in Black/White Patients? Is This the New SoC?

FEATURING Ajay Nooka
  • 18 views
  • November 9, 2020
20:02

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Updates on R/R MM: How Promising Are BCMA Targeted Approaches? Is Belantamab Mafodotin Beneficial for the Survival Outcome? What Is the Safety and Efficacy of Recent CAR-T Studies?

FEATURING Nikhil Munshi
  • 20 views
  • November 9, 2020
09:54

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Next Steps in MM: Does MRD Response Equate With Duration? What Is the Role of Immunotherapy?

FEATURING Sagar Lonial
  • 164 views
  • October 27, 2020